<DOC>
	<DOC>NCT03009916</DOC>
	<brief_summary>The aim of this study is to examine the influence of BAM on postprandial GLP--1 secretion and glucose homeostasis, both with and without bile acid sequestration.</brief_summary>
	<brief_title>Bileacid Malabsorption and GLP-1 Secretion</brief_title>
	<detailed_description />
	<mesh_term>Malabsorption Syndromes</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<mesh_term>Bile Acids and Salts</mesh_term>
	<criteria>Northern European origin Normal haemoglobin Age above 18 years and below 70 years Informed and written consent BMI &gt; 23 kg/m2 and &lt; 35 kg/m2 Normal fasting plasma glucose (FPG) &lt; 6.5 mM) and glycated haemoglobin (HbA1c) &lt; 48 mmol/mol Liver disease (alanine aminotransferase (ALAT) and/or serum aspartate aminotransferase (ASAT) &gt;2 times normal values) or history of hepatobiliary disorder Gastrointestinal disease (except BAM), previous intestinal resection, cholecystectomy or any major intraabdominal surgery Firstdegree relatives with diabetes Nephropathy (serum creatinine &gt;150 ÂµM and/or albuminuria Treatment with medicine that cannot be paused for 12 hours Hypothyroidism or hyperthyroidism Treatment with oral anticoagulants Active or recent malignant disease Any treatment or condition requiring acute or subacute medical or surgical intervention Lack of effective birth control in premenopausal women Any condition considered incompatible with participation by the investigators</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>